Liquid Biopsy
Liquid Biopsy is a medical procedure with 47 clinical trials. Currently 22 active trials ongoing. Historical success rate of 42.9%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
42.9%
3 of 7 finished
57.1%
4 ended early
22
trials recruiting
47
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
Biomarkers to Detect Endocrine Therapy Resistance
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Clinical Trials (47)
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
Biomarkers to Detect Endocrine Therapy Resistance
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
Accelerating Lung Cancer Diagnosis Through Liquid Biopsy
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
Fluid Biopsy for the Diagnosis of Lung Cancer
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer
Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer
Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 47